These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22271863)

  • 21. Effect of artesunate on Toxoplasma gondii: in vitro and in vivo studies.
    El Zawawy LA
    J Egypt Soc Parasitol; 2008 Apr; 38(1):185-201. PubMed ID: 19143130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketolide ABT-773 is active against Toxoplasma gondii.
    Khan AA; Araujo FG; Craft JC; Remington JS
    J Antimicrob Chemother; 2000 Sep; 46(3):489-92. PubMed ID: 10980181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo activity evaluation and mode of action of broxaldine on Toxoplasma gondii.
    Qiu Y; Zhai B; Bai Y; Lin H; Wu L; Luo W; Shi M; Chen S; Zhang J
    Int J Parasitol Drugs Drug Resist; 2024 Aug; 25():100552. PubMed ID: 38986389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Could metformin modulate the outcome of chronic murine toxoplasmosis?
    Gomaa MM; Nabil El Achy S; Hezema NN
    Acta Trop; 2024 Oct; 258():107339. PubMed ID: 39084481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human toxoplasmosis-Searching for novel chemotherapeutics.
    Antczak M; Dzitko K; Długońska H
    Biomed Pharmacother; 2016 Aug; 82():677-84. PubMed ID: 27470411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zingiber officinale Ameliorates Acute Toxoplasmosis-Induced Pathology in Mice.
    El-Kady AM; Elshazly H; Alsulami MN; Albohiri HH; Alshehri EA; Alfaifi MS; Mohamed K; Wakid MH; Gattan HS; Altwaim SA; Al-Megrin WAI; Almalki GH; Abdel-Rahman IAM; Elshabrawy HA; Younis S
    Acta Parasitol; 2024 Sep; ():. PubMed ID: 39225734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Investigation of combined effectiveness of spiramycin and beta-glucan in mice models of acute toxoplasmosis and determination of IL-10, IL-12 and TNF-α levels].
    Büyükbaba Boral O; Sönmez Tamer G; Keçeli Özcan S; Sönmez N; Işsever H; Tekeli F
    Mikrobiyol Bul; 2012 Jul; 46(3):446-55. PubMed ID: 22951656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc oxide nanoparticles produced by Zingiber officinale ameliorates acute toxoplasmosis-induced pathological and biochemical alterations and reduced parasite burden in mice model.
    El-Kady AM; S Hassan A; Mohamed K; Alfaifi MS; Elshazly H; Alamri ZZ; Wakid MH; Gattan HS; Altwaim SA; Al-Megrin WAI; Younis S
    PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011447. PubMed ID: 37410712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The superior efficacy of chloroquine over buparvaquone in reducing the chronic cerebral Toxoplasma gondii cysts load and improving the ultrastructural pathology in an immunocompromised murine model.
    Fahmy MEA; Abdel-Aal AA; Hassan SI; Shalaby MA; Esmat M; Abdel Shafi IR; Afife AA; Shaheen HAA
    Trop Biomed; 2023 Mar; 40(1):115-123. PubMed ID: 37356011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of spiramycin against Toxoplasma gondii in vitro, in experimental infections and in human infection.
    Chang HR; Pechère JC
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():87-92. PubMed ID: 3182450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of spiramycin versus aminoguanidine and their combined use in experimental toxoplasmosis.
    Omar M; Abaza BE; Mousa E; Ibrahim SM; Rashed HE; Farag TI
    J Parasit Dis; 2021 Dec; 45(4):1014-1025. PubMed ID: 34789985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
    Araujo FG; Shepard RM; Remington JS
    Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of the initial site of Toxoplasma gondii reactivation in brain tissue.
    Takashima Y; Suzuki K; Xuan X; Nishikawa Y; Unno A; Kitoh K
    Int J Parasitol; 2008 Apr; 38(5):601-7. PubMed ID: 18022177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of spiramycin for treatment of congenital Toxoplasma gondii infection in rhesus monkeys.
    Schoondermark-Van de Ven E; Melchers W; Camps W; Eskes T; Meuwissen J; Galama J
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1930-6. PubMed ID: 7811000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8-/- mice.
    Jost C; Reiter-Owona I; Liesenfeld O
    Parasitol Res; 2007 Nov; 101(6):1603-9. PubMed ID: 17846793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii.
    Araujo FG; Huskinson J; Remington JS
    Antimicrob Agents Chemother; 1991 Feb; 35(2):293-9. PubMed ID: 2024964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on the therapeutics of experimental toxoplasmosis. I. Effect of acetylspiramycin and spiramycin on the intracardiac Toxoplasma multiplication in mice infected with Toxoplasma gondii (author's transl)].
    Espinas FM; Odakura Y; Suzuki N; Sasaki H
    Jpn J Antibiot; 1981 Aug; 34(8):1141-7. PubMed ID: 7321193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: implications for the behavioral manipulation hypothesis.
    Berenreiterová M; Flegr J; Kuběna AA; Němec P
    PLoS One; 2011; 6(12):e28925. PubMed ID: 22194951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The powerful synergistic effect of spiramycin/propolis loaded chitosan/alginate nanoparticles on acute murine toxoplasmosis.
    Hagras NA; Mogahed NMFH; Sheta E; Darwish AA; El-Hawary MA; Hamed MT; Elwakil BH
    PLoS Negl Trop Dis; 2022 Mar; 16(3):e0010268. PubMed ID: 35294434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiparasitic effects of oxymatrine and matrine against Toxoplasma gondii in vitro and in vivo.
    Zhang X; Jin L; Cui Z; Zhang C; Wu X; Park H; Quan H; Jin C
    Exp Parasitol; 2016 Jun; 165():95-102. PubMed ID: 26993085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.